DUAKLIR ® PRESSAIR ® (aclidinium bromide/formoterol fumarate inhalation powder) is a prescription medicine that is used to treat chronic obstructive pulmonary disease (COPD).

Nov 25, 2024 · Duaklir Pressair is a prescription medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including …

DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive...

Aug 18, 2024 · Overview: Duaklir Pressair (aclidinium/formoterol) is an inhaler used for chronic obstructive pulmonary disease (COPD). It relaxes the muscles around the airways and helps …

Dec 9, 2021 · Duaklir Pressair (aclidinium / formoterol) is a combination of two medications in one inhaler that helps control symptoms of chronic obstructive pulmonary disease (COPD) when …

DUAKLIR ® PRESSAIR ® inhalation powder is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a long-acting beta 2 -adrenergic agonist or LABA) …

Jul 29, 2025 · Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). The approved …

Feb 21, 2024 · Duaklir Pressair (Aclidinium Bromide and Formoterol Fumarate Inhalation Powder) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and …

Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: aclidinium and formoterol. Both drugs work by relaxing the muscles around the …

Medscape - COPD dosing for Duaklir Pressair (aclidinium/formoterol inhaled), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation …